news El Financiero 2026-08-19

Moderna and Merck cancer vaccine shows success in melanoma trial

A personalized cancer vaccine from Moderna and Merck demonstrated a reduction in melanoma recurrence, marking a major success in mRNA-based cancer therapies.

Support Your Local Toad

The Pesky Toad is free and ad-light. If you find it useful, toss a few pesos in the tip jar to help keep the servers running and the satire flowing.

$

MXN · Minimum $10